David Weinstein

1.3k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

David Weinstein is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David Weinstein has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David Weinstein's work include Urinary Bladder and Prostate Research (5 papers), Antifungal resistance and susceptibility (4 papers) and Pelvic floor disorders treatments (4 papers). David Weinstein is often cited by papers focused on Urinary Bladder and Prostate Research (5 papers), Antifungal resistance and susceptibility (4 papers) and Pelvic floor disorders treatments (4 papers). David Weinstein collaborates with scholars based in United States, United Kingdom and France. David Weinstein's co-authors include Vik Khullar, Caty Ebel Bitoun, Christopher R. Chapple, Zahava Gabriel, Dominic Muston, John H. Laragh, Andreas P. Niarchos, Martin C. Michel, Amanda Darekar and Matthias Oelke and has published in prestigious journals such as JAMA, Neurology and Clinical Infectious Diseases.

In The Last Decade

David Weinstein

19 papers receiving 974 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

2008 601 citations Christopher R. Chapple, Vik Khullar et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Weinstein United States	11	663	585	524	126	116	20	1.0k
İlker Şeçkiner Türkiye	14	267 0.4×	190 0.3×	49 0.1×	18 0.1×	150 1.3×	65	705
A. E. Nilson Sweden	15	401 0.6×	106 0.2×	90 0.2×	20 0.2×	636 5.5×	49	1.2k
Ernst P. van Haarst Netherlands	13	250 0.4×	230 0.4×	212 0.4×	6 0.0×	190 1.6×	22	599
Luigi Cataldi Italy	15	243 0.4×	34 0.1×	249 0.5×	15 0.1×	76 0.7×	29	814
Nurcan Cengız Türkiye	14	62 0.1×	52 0.1×	124 0.2×	23 0.2×	92 0.8×	51	716
B Jakobsson Sweden	17	520 0.8×	28 0.0×	474 0.9×	13 0.1×	118 1.0×	24	1.0k
Bhanu Prasad Canada	15	62 0.1×	54 0.1×	113 0.2×	18 0.1×	89 0.8×	82	688
Jalees Fatima India	14	34 0.1×	39 0.1×	103 0.2×	98 0.8×	46 0.4×	44	483
Tetsuo Kato Japan	15	76 0.1×	74 0.1×	62 0.1×	56 0.4×	454 3.9×	47	792
Ayhan Karakoç Türkiye	16	25 0.0×	55 0.1×	109 0.2×	19 0.2×	103 0.9×	44	846

Countries citing papers authored by David Weinstein

Since Specialization

Citations

This map shows the geographic impact of David Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Weinstein more than expected).

Fields of papers citing papers by David Weinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Weinstein. The network helps show where David Weinstein may publish in the future.

Co-authorship network of co-authors of David Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Weinstein. A scholar is included among the top collaborators of David Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Weinstein. David Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwebke, Jane R., Ryan Sobel, Janet Gersten, et al.. (2021). Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clinical Infectious Diseases. 74(11). 1979–1985. 62 indexed citations

Weinstein, David, et al.. (2020). Efficacy of intralesional sodium thiosulfate for the treatment of dystrophic calcinosis cutis: A double-blind, placebo-controlled pilot study. JAAD International. 1(2). 114–120. 10 indexed citations

Davaro, Facundo, David Weinstein, Sameer Siddiqui, & Zachary Hamilton. (2020). A Lack of Palliative Therapy Use in Patients With Advanced Penile Cancer. Journal of Palliative Care. 36(2). 98–104. 12 indexed citations

Cahill, Alison G., Sindhu K. Srinivas, Alan Tita, et al.. (2019). Effect of Immediate vs Delayed Pushing on Rates of Spontaneous Vaginal Delivery Among Nulliparous Women Receiving Neuraxial Analgesia: A Randomized Clinical Trial. Obstetrical & Gynecological Survey. 74(3). 131–133. 4 indexed citations

Cahill, Alison G., Sindhu K. Srinivas, Alan Tita, et al.. (2018). Effect of Immediate vs Delayed Pushing on Rates of Spontaneous Vaginal Delivery Among Nulliparous Women Receiving Neuraxial Analgesia. JAMA. 320(14). 1444–1444. 65 indexed citations

Weinstein, David, et al.. (2017). CHS-131, A Novel Once Daily Oral Treatment, Decreased Lesion Burden of Patients with Relapsing-Remitting Course of Multiple Sclerosis (RRMS) in a Randomized, Double-blind, Phase 2b, Multicenter Study (S50.002). Neurology. 88(16_supplement). 6 indexed citations

Auzinger, Georg, E. Geoffrey Playford, Christopher N. Graham, et al.. (2015). Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC Infectious Diseases. 15(1). 463–463. 13 indexed citations

Bow, Eric J., David J. Vanness, Monica A. Slavin, et al.. (2015). Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. BMC Infectious Diseases. 15(1). 128–128. 44 indexed citations

Barnes, Rosemary A., Stephanie Earnshaw, Raoul Herbrecht, et al.. (2015). Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients. Clinical Therapeutics. 37(6). 1317–1328.e2. 26 indexed citations

10.

Khullar, Vik, Daniela Marschall‐Kehrel, Montserrat Espuña‐Pons, et al.. (2013). European content validation of the Self-Assessment Goal Achievement (SAGA) questionnaire in patients with overactive bladder. International Urogynecology Journal. 24(9). 1529–1536. 5 indexed citations

11.

Wagg, Adrian, Vik Khullar, Daniela Marschall‐Kehrel, et al.. (2013). Flexible‐Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double‐Blind, Placebo‐Controlled Study of Fesoterodine in an Aging Population Trial. Journal of the American Geriatrics Society. 61(2). 185–193. 87 indexed citations

12.

Wagg, Adrian, Vik Khullar, Daniela Marschall‐Kehrel, et al.. (2011). Efficacy and Tolerability of Fesoterodine in Older People With Overactive Bladder: Results of the Open-Label Phase of the SOFIA Trial. 1 indexed citations

13.

Gold, Deborah T., David Weinstein, Gerhardt Pohl, et al.. (2011). Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study. Journal of Osteoporosis. 2011. 1–7. 9 indexed citations

14.

Nelson, Mark, Martin Fisher, Juan González‐García, et al.. (2010). Impact of Baseline Antiretroviral Resistance Status on Efficacy Outcomes Among Patients Receiving Maraviroc Plus Optimized Background Therapy in the MOTIVATE 1 and 2 Trials. HIV Clinical Trials. 11(3). 145–155. 1 indexed citations

15.

Coyne, Karin S., Christopher Sexton, David Weinstein, et al.. (2009). THE PREVALENCE OF OAB IN THE US, UK, AND SWEDEN: RESULTS FROM EPILUTS. The Journal of Urology. 181(4S). 160–160. 3 indexed citations

16.

Chapple, Christopher R., Vik Khullar, Zahava Gabriel, et al.. (2008). The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. European Urology. 54(3). 543–562. 601 indexed citations breakdown →

17.

Weinstein, David, Jay S. Cohen, Chaofeng Liu, et al.. (2006). Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations). Current Medical Research and Opinion. 22(11). 2121–2129. 6 indexed citations

18.

Wall, Donna A., et al.. (1997). Feasibility of an Obstetrician-Based Cord Blood Collection Network for Unrelated Donor Umbilical Cord Blood Banking. The Journal of Maternal-Fetal & Neonatal Medicine. 6(6). 320–323. 5 indexed citations

19.

Niarchos, Andreas P., Lawrence M. Resnick, David Weinstein, & John H. Laragh. (1985). Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy. The American Journal of Medicine. 79(4). 435–444. 17 indexed citations

20.

Niarchos, Andreas P., David Weinstein, & John H. Laragh. (1984). Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension. The American Journal of Medicine. 77(6). 1061–1068. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact